Samsung Montelukast Granules 4mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Prescription medication
Samsung Pharm Co., Ltd.
MFDS item code 201904222 · Approved 2019.06.18
This product's status changed to Expired on 2024.06.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and long-term treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis
This medication helps in the prevention and ongoing treatment of asthma. It is also used to alleviate the symptoms of seasonal and perennial allergic rhinitis.
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 packet once daily in the evening. This 4 mg granule formulation may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as infant formula, breast milk, or porridge, at or below room temperature. Do not open the package until immediately before use. After opening, take the entire contents immediately (within 15 minutes), either mixed with infant formula, breast milk, or food, or directly. Do not leave this medicine mixed with infant formula, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant formula or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.
Asthma: Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Asthma: Infants 12 months to under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Asthma: The efficacy and safety of this medicine for asthma have not been established in infants under 12 months of age. Allergic rhinitis: Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Seasonal allergic rhinitis: The efficacy and safety of this medicine for seasonal allergic rhinitis have not been established in infants under 2 years of age. Perennial allergic rhinitis: Infants 6 months to under 2 years of age: Administer 4mg of this medicine orally once daily. Perennial allergic rhinitis: The efficacy and safety of this medicine for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication should not be used in patients who have an allergic reaction to this medication or its components. Various side effects such as fatigue, headache, abdominal pain, fever, cough, nasal congestion, rash, etc. may occur during the use of this medication; if abnormal symptoms persist or worsen, consultation with a physician is recommended. Particularly, it is also usable in children and adolescents, but caution is needed as the dosage and frequency of side effects may vary by age. This medication is not intended for the treatment of acute asthma attacks; separate emergency medications should be used when acute symptoms arise, and it is important to always carry a rescue inhaler. Inhaled corticosteroids should not be abruptly discontinued or rapidly switched to this medication; they should be gradually adjusted according to a physician's instructions. To prevent exercise-induced bronchospasms, this medication should not be used alone; it is necessary to use an inhaled beta-agonist concurrently. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not take these medications while on this medication. Rarely, systemic eosinophilia associated with vasculitis may appear during the use of this medication; if skin rashes, worsening pulmonary symptoms, or cardiac issues occur, immediate medical attention should be sought. No specific drug interactions have been reported when this medication is used with other asthma treatments, but caution is needed when taking it with drugs that induce certain liver metabolic enzymes. Safety during pregnancy or breastfeeding has not been fully established; consultation with a physician is necessary before taking this medication. It is also usable in children and the elderly, but caution is needed as drug responses may vary by age. In case of overdose, there is no specific antidote, so general supportive treatment and medical monitoring are necessary. This medication is light-sensitive; it should not be opened until just before use, and it is preferable to mix it with soft foods or milk and consume it immediately. It must be stored in a secure place out of the reach of children, and transferring it to other containers helps maintain its quality. This medication must be taken continuously even when asthma symptoms are absent to prevent symptoms; if symptoms worsen, immediate consultation with a physician is necessary. If symptoms related to the nervous system or mental state, such as anxiety, depression, or changes in behavior occur during treatment, the physician must be informed immediately. While taking this medication, do not reduce or discontinue the dosage of other asthma treatments without a physician's instructions, and always carry a rescue inhaler.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air, moisture, and light, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. Proper storage preserves the medication's effectiveness.
A homogeneous granule that is white and free from foreign matter
4mg/unit, 4mg/unit x 28
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Prescription medication
Samsung Pharm Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.